Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 24, 2022

SELL
$35.2 - $52.6 $972,822 - $1.45 Million
-27,637 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$46.35 - $59.75 $38,794 - $50,010
-837 Reduced 2.94%
27,637 $1.35 Million
Q2 2021

Jul 15, 2021

SELL
$47.2 - $67.81 $46,586 - $66,928
-987 Reduced 3.35%
28,474 $1.5 Million
Q1 2021

May 13, 2021

BUY
$30.93 - $59.48 $911,228 - $1.75 Million
29,461 New
29,461 $1.64 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.7B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Virtue Capital Management, LLC Portfolio

Follow Virtue Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtue Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtue Capital Management, LLC with notifications on news.